---
document_datetime: 2025-06-20 15:19:39
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/jakavi-epar-all-authorised-presentations_en.pdf
document_name: jakavi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.754686
conversion_datetime: 2025-12-25 09:15:38.535295
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging         | Content (concentration)   | Pack size                                            |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------------|---------------------------|------------------------------------------------------|
| EU/1/12/773/004  | Jakavi            | 5 mg       | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 14 tablets                                           |
| EU/1/12/773/005  | Jakavi            | 5 mg       | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 56 tablets                                           |
| EU/1/12/773/006  | Jakavi            | 5 mg       | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 168 (3x56) tablets (multipack)                       |
| EU/1/12/773/007  | Jakavi            | 15 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 14 tablets                                           |
| EU/1/12/773/008  | Jakavi            | 15 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 56 tablets                                           |
| EU/1/12/773/009  | Jakavi            | 15 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 168 (3x56) tablets (multipack)                       |
| EU/1/12/773/010  | Jakavi            | 20 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 14 tablets                                           |
| EU/1/12/773/011  | Jakavi            | 20 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 56 tablets                                           |
| EU/1/12/773/012  | Jakavi            | 20 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 168 (3x56) tablets (multipack)                       |
| EU/1/12/773/014  | Jakavi            | 10 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 14 tablets                                           |
| EU/1/12/773/015  | Jakavi            | 10 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 56 tablets                                           |
| EU/1/12/773/016  | Jakavi            | 10 mg      | Tablet                | Oral use                  | blister (PVC/PE/PVDC/ a lu) |                           | 168 (3x56) tablets (multipack)                       |
| EU/1/12/773/017  | Jakavi            | 5 mg/ml    | Oral solution         | Oral use                  | bottle (glass)              | 60 ml                     | 1 bottle + 2 oral syringes + press-in bottle adapter |